BodyNord ApS: Financial statements 2023
CVR: 42174262
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BodyNord ApS (CVR 42174262) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 663,411 and a net result of DKK 20,045 compared with DKK -70,010 the year before. That is an increase of 5.1% compared with the year before. Equity in the 2023 report amounted to DKK 4,320. The solvency ratio was 2.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 663,411
- Profit/Loss
- DKK 20,045
- Equity
- DKK 4,320
- Total Assets
- DKK 202,117
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 663K | 20K | 4K | 2 |
| 2022 | - | 631K | -70K | -16K | 2 |
| 2021 | - | 729K | 14K | 54K | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BodyNord ApS has published its annual report for 2022. Gross profit came to DKK 631,253, and the net result was DKK -70,010.
About BodyNord ApS
BodyNord ApS is a Danish company of the type Anpartsselskab based in Gistrup, founded in 2021. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Skurebørsten ApS. The management consists of Gitte Bjørk Dahl. The company is owned by Gitte Bjørk Dahl. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -85,065 and a net result of DKK -317,139 compared with DKK -339,809 the year before. Equity in the 2025 report amounted to DKK -652,628.